000 | 01423 a2200397 4500 | ||
---|---|---|---|
005 | 20250513040253.0 | ||
264 | 0 | _c19930610 | |
008 | 199306s 0 0 eng d | ||
022 | _a0885-4505 | ||
024 | 7 |
_a10.1006/bmmb.1993.1022 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpence, W C | |
245 | 0 | 0 |
_aNeonatal screening for cystic fibrosis: addition of molecular diagnostics to increase specificity. _h[electronic resource] |
260 |
_bBiochemical medicine and metabolic biology _cApr 1993 |
||
300 |
_a200-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aCystic Fibrosis _xdiagnosis |
650 | 0 | 4 | _aCystic Fibrosis Transmembrane Conductance Regulator |
650 | 0 | 4 |
_aDNA _xanalysis |
650 | 0 | 4 | _aExons |
650 | 0 | 4 | _aGene Deletion |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aNeonatal Screening |
650 | 0 | 4 |
_aPennsylvania _xepidemiology |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
650 | 0 | 4 |
_aTrypsinogen _xblood |
700 | 1 | _aPaulus-Thomas, J | |
700 | 1 | _aOrenstein, D M | |
700 | 1 | _aNaylor, E W | |
773 | 0 |
_tBiochemical medicine and metabolic biology _gvol. 49 _gno. 2 _gp. 200-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/bmmb.1993.1022 _zAvailable from publisher's website |
999 |
_c7682902 _d7682902 |